Lessons learnt from the application of the HEcoPerMed guidance to three modelling case studies - Supplementary material

Abstract

Appendix Table 1 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the NTRK case studyAppendix Table 2 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the ToxNav case studyAppendix Table 3 Recommendations of the Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine applied in the MODY case stud